Skip to content
10-Q

Quarterly Report

Crinetics Pharmaceuticals, Inc. CRNX

0001658247-25-000019

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 28, 2025 94.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 94.22M sh
Shares Diluted Q3 2025 · Sep 30, 2025 93.71M sh
Shares Diluted Q3 2025 · Sep 30, 2024 80.09M sh
Shares Diluted Q3 2025 · Sep 30, 2024 77.17M sh
Capex Q3 2025 · Sep 30, 2025 $5.3M
Capex Q3 2025 · Sep 30, 2024 $2.82M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$285.02M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$163.32M
Short Term Investments Q3 2025 · Sep 30, 2025 $981.39M
Short Term Investments Q3 2025 · Dec 31, 2024 $1.09B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $110.9M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $264.55M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $317.27M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.07B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.17B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.32B
Stockholders Equity Q3 2025 · Sep 30, 2024 $832.98M
Stockholders Equity Q3 2025 · Jun 30, 2024 $830.76M
Stockholders Equity Q3 2025 · Dec 31, 2023 $539.11M
Current Liabilities Q3 2025 · Sep 30, 2025 $74.16M
Current Liabilities Q3 2025 · Dec 31, 2024 $59.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $123.86M
Total Liabilities Q3 2025 · Dec 31, 2024 $109.79M
Current Assets Q3 2025 · Sep 30, 2025 $1.12B
Current Assets Q3 2025 · Dec 31, 2024 $1.38B
Total Assets Q3 2025 · Sep 30, 2025 $1.2B
Total Assets Q3 2025 · Dec 31, 2024 $1.43B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.66
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.96
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.82
Eps Basic Q3 2025 · Sep 30, 2025 −$1.38
Eps Basic Q3 2025 · Sep 30, 2025 −$3.66
Eps Basic Q3 2025 · Sep 30, 2024 −$0.96
Eps Basic Q3 2025 · Sep 30, 2024 −$2.82
Rd Expense Q3 2025 · Sep 30, 2025 $90.46M
Rd Expense Q3 2025 · Sep 30, 2025 $247.01M
Rd Expense Q3 2025 · Sep 30, 2024 $61.91M
Rd Expense Q3 2025 · Sep 30, 2024 $173.59M
Net Income Q3 2025 · Sep 30, 2025 −$130.09M
Net Income Q3 2025 · Sep 30, 2025 −$342.5M
Net Income Q3 2025 · Sep 30, 2024 −$76.83M
Net Income Q3 2025 · Sep 30, 2024 −$217.81M
Operating Income Q3 2025 · Sep 30, 2025 −$142.59M
Operating Income Q3 2025 · Sep 30, 2025 −$383.1M
Operating Income Q3 2025 · Sep 30, 2024 −$87.8M
Operating Income Q3 2025 · Sep 30, 2024 −$244.11M
Revenue Q3 2025 · Sep 30, 2025 $143K
Revenue Q3 2025 · Sep 30, 2025 $1.54M
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $1.04M